SCHEMBL18737291

SCHEMBL18737291

C/C=C(\CCP)C(C)(C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10643014 0.74 CES2 (0.32) —
SCHEMBL18931793 0.74 CES2 (0.32) —
SCHEMBL10643011 0.74 CES2 (0.32) —
SCHEMBL22820870 0.72 ALDH1A1 (0.30) —
SCHEMBL23265970 0.69 TSHR (0.33) —
SCHEMBL19424071 0.69 — —
SCHEMBL8931299 0.67 — —
SCHEMBL19177004 0.67 — —
SCHEMBL13370623 0.67 — —
SCHEMBL19356146 0.65 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170137463-A1 HCV PROTEASE INHIBITORS AND USES THEREOF CELGENE CAR LLC (BM) 2017-05-18 — — US disclosed
US-20170100397-A1 HETEROARYL COMPOUNDS AND USES THEREOF BRISTOL-MYERS SQUIBB COMPANY 2017-04-13 — — US disclosed
Send feedback